Inhibrx Biosciences, Inc. Share Price: INBX (Inhibrx Biosciences, Inc. ) Stock Price Today & Updates | INDmoney

Question 1

What is Inhibrx Biosciences, Inc.  share price today?

Accepted Answer

Inhibrx Biosciences, Inc. (INBX) share price today is {{live_price}}.

Question 2

Can Indians buy Inhibrx Biosciences, Inc.  shares?

Accepted Answer

Yes, Indians can invest in the Inhibrx Biosciences, Inc. (INBX) from India.

With INDmoney, you can buy Inhibrx Biosciences, Inc. at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Inhibrx Biosciences, Inc. at zero transaction cost.

Question 3

How can I buy Inhibrx Biosciences, Inc.  shares from India?

Accepted Answer

It is very easy to buy Inhibrx Biosciences, Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Inhibrx Biosciences, Inc.  be purchased?

Accepted Answer

Yes, you can buy fractional shares of Inhibrx Biosciences, Inc. with INDmoney app.

Question 5

What are the documents required to start investing in Inhibrx Biosciences, Inc.  stocks?

Accepted Answer

To start investing in Inhibrx Biosciences, Inc. , You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Inhibrx Biosciences, Inc.

Accepted Answer

Today’s highest price of Inhibrx Biosciences, Inc. (INBX) is {{1_rba_end}}.

Today’s lowest price of Inhibrx Biosciences, Inc. (INBX) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Inhibrx Biosciences, Inc.

Accepted Answer

Today's market capitalisation of Inhibrx Biosciences, Inc.  INBX is 194.7M

Question 8

What is the 52 Week High and Low Range of Inhibrx Biosciences, Inc.

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Inhibrx Biosciences, Inc.  is down from its 52 Week High?

Accepted Answer

Inhibrx Biosciences, Inc.  (INBX) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Inhibrx Biosciences, Inc.  is up from its 52 Week low?

Accepted Answer

Inhibrx Biosciences, Inc.  (INBX) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Inhibrx Biosciences, Inc. ?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Inhibrx Biosciences, Inc.

Accepted Answer

Mr. Mark Paul Lappe is the current Chief Executive Officer (CEO) of Inhibrx Biosciences, Inc. .

Period	Inhibrx Biosciences, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-60.57%	6.5%	0.0%
6 Months	-64.28%	7.1%	0.0%
1 Year	-40.73%	9.8%	0.0%
3 Years	-54.69%	14.2%	-20.2%

Market Capitalization	194.7M
Book Value	$0.24
Earnings Per Share (EPS)	-11.56
Wall Street Target Price	35.5

Profit Margin	0.0%
Operating Margin TTM	-9940.02%

Return On Assets TTM	-57.46%
Return On Equity TTM	-2031.05%

Revenue TTM	1.6M
Revenue Per Share TTM	0.04
Quarterly Revenue Growth YOY	496.40000000000003%
Gross Profit TTM	-108.0M
EBITDA	-161.2M
Diluted Eps TTM	-11.56
Quarterly Earnings Growth YOY	0.0

Inhibrx Biosciences, Inc. (INBX)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Technicals Summary

Peers

Increasing Revenue

Increasing Net Profit

Vs NVO

Vs NVO

Institutional Holdings

Company Information

Discover More

FAQs

EPS Estimate Current Year	-12.6
EPS Estimate Next Year	-8.69
EPS Estimate Current Quarter	-1.04
EPS Estimate Next Quarter	-1.05

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Inhibrx Biosciences, Inc.	-8.14%	-64.28%	-40.73%	-54.69%	-34.9%
Moderna, Inc.	-1.67%	18.26%	-0.21%	-64.15%	752.69%
Regeneron Pharmaceuticals, Inc.	-0.46%	13.21%	45.59%	84.19%	244.2%
Novo Nordisk A/s	-11.0%	18.31%	61.56%	186.46%	423.59%
Vertex Pharmaceuticals Incorporated	3.85%	14.43%	39.88%	147.45%	195.07%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Inhibrx Biosciences, Inc.	NA	NA	NA	-12.6	-20.31	-0.57	NA	0.24
Moderna, Inc.	24.73	NA	0.0	-7.19	-0.38	-0.16	NA	33.47
Regeneron Pharmaceuticals, Inc.	31.35	31.35	1.46	44.44	0.15	0.08	NA	250.15
Novo Nordisk A/s	44.28	44.28	2.36	3.43	1.0	0.25	0.01	22.18
Vertex Pharmaceuticals Incorporated	31.85	31.85	0.53	16.98	0.24	0.13	NA	71.8

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Inhibrx Biosciences, Inc.	Hold	$194.7M	-34.9%	NA	0.0%
Moderna, Inc.	Buy	$45.3B	752.69%	24.73	-115.82%
Regeneron Pharmaceuticals, Inc.	Buy	$116.9B	244.2%	31.35	29.45%
Novo Nordisk A/s	Buy	$572.0B	423.59%	44.28	36.55%
Vertex Pharmaceuticals Incorporated	Buy	$126.7B	195.07%	31.85	39.46%

Organization	Inhibrx Biosciences, Inc.
Employees	0
CEO	Mr. Mark Paul Lappe
Industry	Health Technology